Literature DB >> 8007594

Adenoviral-mediated gene transfer to renal tubular cells in vivo.

P Moullier1, G Friedlander, D Calise, P Ronco, M Perricaudet, N Ferry.   

Abstract

The efficient introduction of genetic material into quiescent renal cells is potentially important in the study of renal physiopathology and for gene therapy of kidney related disorders. A replication-deficient adenoviral vector that contained a reporter gene encoding the nuclear beta-galactosidase was either selectively perfused into the renal artery or infused through a retrograde catheter into the pyelic cavity of the left kidney of adult rats. Highly efficient gene transfer was achieved by either route of administration, and nuclear beta-galactosidase activity was detected for two to four weeks following a progressive decline of expression. Genetically-modified cells were identified as proximal tubular cells when the adenoviral vector was selectively perfused via the renal artery, while tubular cells from the papilla and medulla were selectively transduced by retrograde infusion of the viral vector. No obvious cytopathic effect was observed. We conclude that: (i) efficient gene transfer in renal tubular cells can be achieved by adenoviral vectors; (ii) the targeted cell population can be chosen through the route of administration.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8007594     DOI: 10.1038/ki.1994.162

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  20 in total

1.  Gene therapy to the kidney using viral vectors.

Authors:  Talha Akbulut; Frank Park
Journal:  Paidiatrike       Date:  2008

2.  Creation of a reversible on/off system for site-specific in vivo control of exogenous gene activity in the renal glomerulus.

Authors:  M Kitamura
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

Review 3.  Improving Molecular Therapy in the Kidney.

Authors:  Jeffrey D Rubin; Michael A Barry
Journal:  Mol Diagn Ther       Date:  2020-08       Impact factor: 4.074

Review 4.  Gene therapy targeting kidney diseases: routes and vehicles.

Authors:  Yoshitaka Isaka
Journal:  Clin Exp Nephrol       Date:  2006-12-20       Impact factor: 2.801

5.  Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism.

Authors:  V N Krasnykh; G V Mikheeva; J T Douglas; D T Curiel
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

6.  A method to facilitate and monitor expression of exogenous genes in the rat kidney using plasmid and viral vectors.

Authors:  Peter R Corridon; George J Rhodes; Ellen C Leonard; David P Basile; Vincent H Gattone; Robert L Bacallao; Simon J Atkinson
Journal:  Am J Physiol Renal Physiol       Date:  2013-03-06

7.  Reconstitution of mutant V2 vasopressin receptors by adenovirus-mediated gene transfer. Molecular basis and clinical implication.

Authors:  T Schöneberg; V Sandig; J Wess; T Gudermann; G Schultz
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

8.  Comparison of Gene Delivery to the Kidney by Adenovirus, Adeno-Associated Virus, and Lentiviral Vectors After Intravenous and Direct Kidney Injections.

Authors:  Jeffrey D Rubin; Tien V Nguyen; Kari L Allen; Katayoun Ayasoufi; Michael A Barry
Journal:  Hum Gene Ther       Date:  2019-12-03       Impact factor: 5.695

Review 9.  Gene therapy on renal-cell carcinoma: magic bullet or tragic insanity?

Authors:  G H Mickisch
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

10.  Comparison of the transduction efficiency of tyrosine-mutant adeno-associated virus serotype vectors in kidney.

Authors:  Yan F Qi; Qiu H Li; Vinayak Shenoy; Michael Zingler; Joo Y Jun; Amrisha Verma; Michael J Katovich; Mohan K Raizada
Journal:  Clin Exp Pharmacol Physiol       Date:  2013-01       Impact factor: 2.557

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.